LATEST COVID-19 STUDIES

 

Henry Ford Hospital study shows HCQ may reduce mortality over 50% in early hospital use

 

Zelenko et al publishes study of outpatient HCQ use with 99.3% outpatient survival rate

 

Raoult et al reports only 0.5% mortality rate in 3,737 COVID-19 patients treated with HCQ+AZ

 

NEJM study on hydroxychloroquine for post-exposure prophylaxis shows no benefit and no harm

 

American Journal of Epidemiology..."Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis"

 

Lancet study of HCQ treatment in sick, hospitalized patients MORE THAN 10 DAYS after symptom onset. Authors admit data does NOT apply to HCQ treatment in an ambulatory or outpatient setting (MR Mehra, et al)

 

S. Korea prospective trial in long-term care hospitals on prophylaxis with HCQ was 100% protective in 211 patients...Over 2 months and 30,000 LTCH deaths later, the US struggles to publish its 1st HCQ prophylaxis study (SH Lee, et al)

 

EARLY treatment with HCQ (mean time 5.6 days from symptom onset) decreases both hospital stay and time to viral clearance compared to lopinavir-ritonavir (MS Kim, et al)

 

ZINC shown to amplify efficacy of HCQ + AZ treatment regimen in hospitalized patients (J Rahimian, et al)

No surprise...BMJ study finds HCQ ineffective once patients are already in cytokine storm (M Mahévas, et al)

Hydroxychloroquine increases survival in EARLY treatment of COVID-19 (FJ Membrillo, et al)

HCQ + AZ reduces transfer to ICU and death compared to standard therapy...p=0.002 (B Davido, et al)

 

Early treatment of COVID-19 with HCQ and AZ results in 98.7% cure rate in study of 1061 cases in France (D Raoult, et al)

NY study FAILS to evaluate EARLY treatment with HCQ, and becomes just another study looking at treatment after cytokine storm (ES Rosenberg et al)

American Health Association: "In the largest reported cohort of COVID-19 patients to date treated with chloroquine/hydroxychloroquine {plus minus} azithromycin, no instances of TdP or arrhythmogenic death were reported." (M Saleh, et al)

 

Widespread antibody testing shows 5% of Spaniards have contracted coronavirus (Ministry of Health, Spain)

Remdesivir WITHOUT clinical benefit in randomized placebo-controlled trial (Y Wang, et al)

Prospective study at Prevent Senior Institute in São Paulo, Brazil shows EARLY outpatient treatment with HCQ + AZ results in DECREASED need for hospitalization (RB Esper, et al)

Todaro MD, Krug, Praver MD and Zelenko MD propose strategy to reopen America with hydroxychloroquine and age-based self-quarantining (JM Todaro, et al)

Pharmacokinetics study proposes new HCQ dosage for faster time to therapeutic levels (S Perinel, et al)

RCT of HCQ vs standard therapy resulted in significantly shorter time to temperature recovery and cough remission (Z Chen, et al)

VA study shows treatment of LATE STAGE COVID-19 with HCQ + AZ is not effective (J Magagnoli, et al)

Didier Raoult publishes landmark study showing all COVID-19 patients treated with HCQ + AZ virologically cured in 6 days (P Gautret, et al)

CENSORED BY GOOGLE The original google doc on "An Effective Treatment for Coronavirus" by Todaro and Rigano (since taken down by Google in March 2020)

 

Archived studies and reports on HCQ/AZ/Zinc in treatment of COVID-19 and antibody prevalence studies can be found in the following Google Doc curated by JM Todaro, MD.

NEWS

 

 

 

Gov Mike DeWine now reverses decision to ban HCQ for COVID-19 in Ohio after mounting pressure overnight

 

America's Frontline Doctors video censored by Facebook, YouTube, Twitter after going viral in just hours

 

A Study Out of Thin Air (MedicineUncensored original article) leads to retraction of Lancet study

 

LANCET STUDY RETRACTED...in just 13 days

 

WHO coincidentally resumes clinical trials on HCQ right as #LancetGate hits mainstream news

 

The Guardian publishes scathing investigative report on Surgisphere, referencing MedicineUncensored!

Lancet now publishes its own Expression of Concern over the Surgisphere study!

 

NEJM publishes "Substantive concerns" with Surgisphere database...Is retraction next?

 

Lancet study on HCQ caught with fake data! Hospitals deny ever sharing data with the mysterious Surgisphere Corp

 

India expands prophylactic use of HCQ after successful prevention studies while US is held back by politics and media gamesmanship

 

CDC report confirms estimates of low fatality and hospitalization rates of COVID-19...IFR ~0.3%

 

Media no longer interested in Florida after underwhelming death counts weeks after reopening

 

Worldwide placebo-controlled trial of hydroxychloroquine prophylaxis in 40,000 healthcare workers begins! Don't hold your breath...results not expected until end of year

 

News of “ICUs full of healthy young people” exaggerated morbidity fears...If infected with COVID-19, actual risk of needing any hospitalization is only 0.9% for New Yorkers between 18 and 44 years of age

 

NO DEATHS among Mumbai policemen/women who took hydroxychloroquine prophylaxis compared to 9 deaths in those who refused

 

NY Times data on nursing homes shows states where "new cases are increasing" have the highest share of nursing home deaths from COVID-19 (52% vs 35%)...Yet media continues to focus on beaches as opposed to protecting nursing homes

 

Praised as a “Brave Thinker” by The Atlantic in 2010, Stanford Prof John Ioannidis is now vilified for his antibody study that challenged the media-driven COVID-19 lockdown

 

IVERMECTIN results in complete recovery from COVID-19 in under 4 days in trial of 60 patients

Outbreaks in meat plants imply workforce infection fatality rate is 0.2%!

Trump threatens to permanently pull funding from World Health Organization

NIH begins enrollment in national trial of HCQ + AZ for COVID-19, including PREGNANT WOMEN

Government lockdown in Spain results in HIGHER infection rates in those over age 60 who stayed home!

Over 3000 COVID-19 patients treated at IHU-Marseille with HCQ + AZ with only 18 deaths...Case Fatality Rate of 0.5%

SERMO survey of over 6,000 physicians still shows HCQ and azithromycin to be standard treatments for COVID-19 despite media assault

Seasonal flu/pneumonia results in more life-years lost than COVID-19 during same period in 2020

No mortality benefit? No worries...Gilead's Remdesivir praised by Fauci and approved for emergency use anyway

 

PayPal mafia's Keith Rabois discusses Trump Derangement Syndrome surrounding HYDROXYCHLOROQUINE

Top critic of Didier Raoult cited in New York Times feature linked to Gilead and Remdesivir!

Raoult exposes 3 critical biases in infamous VA study of hydroxychloroquine

Association of American Physicians and Surgeons to Arizona Gov: "RESCIND YOUR EXECUTIVE ORDERS IMPEDING THE USE OF CQ AND HCQ"

National Task Force for COVID-19 in India recommends hydroxychloroquine prophylaxis for healthcare workers

Elon Musk content on COVID-19 censored by Google yet again! 

VIDEOS

 

CENSORED: America's Frontline Doctors Press Conference at the Supreme Court

 

 

 

 

"Twenty-one billion reasons to discredit hydroxychloroquine"

CENSORED BY YOUTUBE Bakersfield doctors hold a press conference challenging California's stay-at-home order

CENSORED BY YOUTUBE

Professor Dr. Karol Sikora speaks about COVID-19 antibody tests, immunity in the young and possibility that the virus may be burning out naturally

Tips or news stories? Please email jtodaro2@gmail.com

James Todaro, MD received his medical degree from Columbia University, Vagelos College of Physicians and Surgeons in NY, and completed his surgical training with four additional years of residency in ophthalmology.

A long-time advocate of free speech, Dr. Todaro has doggedly pursued the dissemination of vital medical knowledge and evidence during the COVID-19 pandemic, despite censorship by social media platforms and ad hominem attacks by mainstream media outlets.

On March 13, 2020, Dr. Todaro and Gregory Rigano, Esq published the first widely disseminated paper proposing chloroquine and hydroxychloroquine in treatment of COVID-19. The publication was later taken down by Google despite triggering widespread use and ongoing clinical investigation of the drug's effectiveness in over 100 clinical trials.

Disclaimer: The opinions expressed on this page are those of the author(s) and do not reflect the opinions of MedicineUncensored or its Editors. This publication does not constitute medical or professional advice. Information on our page has been obtained by MedicineUncensored from sources believed to be reliable. However, neither MedicineUncensored nor its authors guarantee the accuracy or completeness of any information published herein and neither MedicineUncensored nor its authors shall be responsible for any errors, omissions, or claims for damages, including exemplary damages, arising out of use, inability to use, or with regard to the accuracy or sufficiency of the information contained in this publication. No responsibility is assumed by MedicineUncensored or Editors for any injury and/or damage to persons or property as a matter of product liability, negligence, or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the published content. No suggested test, procedure or treatment should be carried out unless under medical supervision.

©MedicineUncensored.com. All rights reserved.